Dr Annalene Nel leads the International Partnership for Microbicides’ clinical program for the Dapivirine Vaginal Ring, an ARV based microbicide product, which demonstrated safety and efficacy in reducing the risk of HIV-1 infection in women. Apart from steering IPM’s clinical research strategy in Africa, she is passionate about finding HIV prevention solutions for young women in the region and has thus worked closely with communities, governments, regulatory authorities and industry to build a favourable environment for microbicide research.
Over the last 12 years, her efforts into developing clinical research in the region have seen her spearhead efforts to advance global standard health research capacity in sub-Saharan Africa. She is an active member of the Bill & Melinda Gates Foundation’s product development partnership on the Global Health Clinical Consortium and Global Health Regulatory Forum.
Dr Nel is Chief Medical Officer and Executive Vice President at the International Partnership for Microbicides and is based in South Africa. She holds a MBChB, BSc Honours (Clinical Pharmacology, cum laude), a PhD and a Certificate in Senior Business Programme (cum laude) from the University of Stellenbosch.